<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on May 29, 2018</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT00742430</url>
  </required_header>
  <id_info>
    <org_study_id>108-1081875-1993</org_study_id>
    <nct_id>NCT00742430</nct_id>
  </id_info>
  <brief_title>Resistance on Antithrombotic Drugs in Ischemic Heart Disease</brief_title>
  <official_title>Assessment of Aspirin and Clopidogrel Resistance in Ischemic Heart Disease Using Multiplate Function Analyser and it's Correlation With Major Adverse Cardiac Events</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>University of Zagreb</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>University of Zagreb</source>
  <oversight_info>
    <has_dmc>No</has_dmc>
  </oversight_info>
  <brief_summary>
    <textblock>
      The purpose of this study is to determine whether aspirin and clopidogrel resistance measured
      with Multiplate function analyser has a good correlation with incidence of major adverse
      cardiac events in patients with coronary artery disease (CAD).
    </textblock>
  </brief_summary>
  <detailed_description>
    <textblock>
      Our plan is to enroll 180 patients with diagnosed CAD who electively undergo percutaneous
      coronary intervention (PCI). Blood samples will be taken just before the procedure and one
      day after the procedure and analysed on Multiplate function analyser. Assessing aspirin and
      clopidogrel resistance incidence using Multiplate platelet function analyzer we will also try
      to find resistance correlation with the incidence of major adverse cardiac events in a one
      year follow up.
    </textblock>
  </detailed_description>
  <overall_status>Completed</overall_status>
  <start_date>February 2009</start_date>
  <completion_date type="Actual">August 2011</completion_date>
  <study_type>Observational</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <observational_model>Cohort</observational_model>
    <time_perspective>Prospective</time_perspective>
  </study_design_info>
  <primary_outcome>
    <measure>Major adverse coronary event</measure>
    <time_frame>12 months</time_frame>
  </primary_outcome>
  <number_of_groups>2</number_of_groups>
  <enrollment type="Actual">141</enrollment>
  <condition>Coronary Artery Disease</condition>
  <arm_group>
    <arm_group_label>Resistant</arm_group_label>
    <description>patients who are resistant to standard antithrombotic drugs</description>
  </arm_group>
  <arm_group>
    <arm_group_label>Nonresistant</arm_group_label>
    <description>patients who are not resistant to standard dual antithrombotic drugs</description>
  </arm_group>
  <intervention>
    <intervention_type>Procedure</intervention_type>
    <intervention_name>PCI</intervention_name>
    <description>percutaneous coronary intervention in stable coronary artery disease</description>
    <arm_group_label>Resistant</arm_group_label>
    <arm_group_label>Nonresistant</arm_group_label>
    <other_name>stenting</other_name>
    <other_name>PTCA</other_name>
    <other_name>balloon dilatation</other_name>
  </intervention>
  <eligibility>
    <study_pop>
      <textblock>
        patients with coronary artery disease
      </textblock>
    </study_pop>
    <sampling_method>Non-Probability Sample</sampling_method>
    <criteria>
      <textblock>
        Inclusion Criteria:

          -  Elective PCI

          -  &gt; 7 days on aspirin 100mg therapy before the intervention

          -  &gt; 7 days on clopidogrel 75mg therapy before the intervention

        Exclusion Criteria:

          -  Loading dose of clopidogrel

          -  &lt; 7 days on aspirin therapy before the intervention

          -  Myocardial infarction less than 30 days before the intervention

          -  Cerebrovascular incident less that three months before the intervention

          -  Haemorrhagic diathesis

          -  Trc &lt; 100

          -  Htc &lt; 30%

          -  Creatinine &gt; 140
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>N/A</minimum_age>
    <maximum_age>N/A</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Davor Milicic, prof.dr.sc.</last_name>
    <role>Principal Investigator</role>
    <affiliation>Clinic of Cardiovascular Diseases, Clinical Medical Centre Rebro, Zagreb, Croatia</affiliation>
  </overall_official>
  <overall_official>
    <last_name>Bosko Skoric, dr.</last_name>
    <role>Study Chair</role>
    <affiliation>Clinic of Cardiovascular Diseases, Clinical Medical Centre Rebro, Zagreb, Croatia</affiliation>
  </overall_official>
  <location>
    <facility>
      <name>Clinic of Cardiovascular Diseases, Clinical Medical Centre Rebro</name>
      <address>
        <city>Zagreb</city>
        <zip>10000</zip>
        <country>Croatia</country>
      </address>
    </facility>
  </location>
  <location_countries>
    <country>Croatia</country>
  </location_countries>
  <verification_date>February 2012</verification_date>
  <!-- For several months we've had both old and new date name tags                             -->
  <!-- Now, the old date names have been dropped.                                               -->
  <!-- The new date name replacements are:                                                      -->
  <!--     OLD (gone)                                        NEW (in use)                       -->
  <!--   lastchanged_date                         becomes   last_update_submitted               -->
  <!--   firstreceived_date                       becomes   study_first_submitted               -->
  <!--   firstreceived_results_date               becomes   results_first_submitted             -->
  <!--   firstreceived_results_disposition_date   becomes   disposition_first_submitted         -->
  <study_first_submitted>August 26, 2008</study_first_submitted>
  <study_first_submitted_qc>August 26, 2008</study_first_submitted_qc>
  <study_first_posted type="Estimate">August 27, 2008</study_first_posted>
  <last_update_submitted>February 11, 2012</last_update_submitted>
  <last_update_submitted_qc>February 11, 2012</last_update_submitted_qc>
  <last_update_posted type="Estimate">February 14, 2012</last_update_posted>
  <responsible_party>
    <responsible_party_type>Principal Investigator</responsible_party_type>
    <investigator_affiliation>University of Zagreb</investigator_affiliation>
    <investigator_full_name>Davor Milicic</investigator_full_name>
    <investigator_title>prof. dr. sc. F.E.S.C.</investigator_title>
  </responsible_party>
  <keyword>aspirin resistance</keyword>
  <keyword>coronary artery disease</keyword>
  <keyword>clopidogrel resistance</keyword>
  <keyword>major adverse cardiac events</keyword>
  <keyword>multiplate platelet function analyser</keyword>
  <keyword>percutaneous coronary intervention</keyword>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Coronary Artery Disease</mesh_term>
    <mesh_term>Myocardial Ischemia</mesh_term>
    <mesh_term>Coronary Disease</mesh_term>
    <mesh_term>Heart Diseases</mesh_term>
  </condition_browse>
  <intervention_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Aspirin</mesh_term>
    <mesh_term>Clopidogrel</mesh_term>
  </intervention_browse>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

